Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Precision medicine

Diagnostics Omics

A Tipping Point for Comprehensive Genomic Profiling in Cancer

| Cindy Perettie

Precision medicine is key to every aspect of modern oncology – and comprehensive genomic profiling can help

Inside the Lab Technology and innovation

A New Dawn for Comprehensive Genomic Profiling with TruSight™ Oncology 500

| Sponsored by Illumina

Results from early access trials demonstrate the reproducibility and reliability of a pan-cancer next-generation sequencing assay

Inside the Lab Precision medicine

Prognostic Tumor Gene Test for Ovarian Cancer

| Olivia Gaskill

A tumor gene test has been developed that may predict poor survival in patients with ovarian cancer

Inside the Lab Precision medicine

Spatial Biomarkers and Immunotherapy Response

| Cliff Hoyt

To improve immunotherapy outcomes, we need to explore new biomarkers that offer spatial resolution in the tumor microenvironment

Inside the Lab Precision medicine

Think of the Children

| Luke Turner

Two experts in childhood cancers give their take on the intricacies of pediatric laboratory medicine and where they think the field will go next

Inside the Lab Precision medicine

Precision Oncology Flourishes In-House

| Tanya Ahmad

As the UK heads toward test centralization, medical oncologist Tanya Ahmad explains why in-house testing shouldn’t be left behind

Diagnostics Digital and computational pathology

Capturing Cancer Through CTCs

| Michael Schubert

A new algorithm may help identify rare circulating tumor cells to improve liquid biopsy

Diagnostics Biochemistry and molecular biology

Deep Learning for Molecular Tumor Biomarker Prediction

| Heather D. Couture

New AI technology uses H&E images to create an alternative path for molecular diagnostics

Inside the Lab Liquid biopsy

Liquid Biopsy Insights into Cancer

| Sponsored by Illumina

Liquid biopsy is minimally invasive and easily accessible – but what information can a new multiplexed assay provide from circulating tumor DNA?

Subspecialties Oncology

Building a Cancer-Free World Through MRD Testing

| Sponsored by Adaptive Biotechnologies

Minimal residual disease testing by immunosequencing can yield vital information about patients’ disease and management

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register